Peringkat dalam Saham
#42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$581.00
Perubahan (1 tahun)
0.00%
Perdagangan Adynxx, Inc. (ADYX)
Harga ADYX dengan kapitalisasi pasar B
Kapitalisasi pasar dari Adynxx, Inc.(ADYX)
Kapitalisasi Pasar: $581.00
Per August 2026, Adynxx, Inc. memiliki kapitalisasi pasar sebesar $581.00. Ini menjadikan Adynxx, Inc. sebagai perusahaan 42632nd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Adynxx, Inc. dari 1998 hingga 2026
ADYX dibandingkan dengan 5 teratas stocks paling populer
| Harga ADYX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.426T
|
+933,905,081,394.49%
|
|
|
|
|
$4.437T
|
+763,666,673,572.98%
|
|
|
|
|
$4.148T
|
+713,856,341,119.11%
|
|
|
|
|
$3.664T
|
+630,609,401,879.35%
|
|
|
|
|
$2.889T
|
+497,289,068,574.70%
|
